FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...
Biogen Inc.: FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...
'I was happy, active and loved climbing Eryri. Then my whole world changed'
Meanwhile, her condition continued to deteriorate. “My whole body felt like it was convulsing,” said Mel. “It was like ...